US Patent Issued to ASSEMBLY BIOSCIENCES on June 16 for "5-membered heteroaryl carboxamide compounds for treatment of HBV" (California Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,655,130, issued on June 16, was assigned to ASSEMBLY BIOSCIENCES INC. (South San Francisco, Calif.).

"5-membered heteroaryl carboxamide compounds for treatment of HBV" was invented by Thilo Heckrodt (South San Francisco, Calif.), Michael Walker (South San Francisco, Calif.) and Min Zhong (South San Francisco, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to 5-membered heteroaryl carboxamide compounds, which may disrupt Hepatitis B (HBV) core protein assembly. The present disclosure further relates to pharmaceutical compositions comprising 5-membered heteroaryl carboxamide compounds which may disrupt HBV core protei...